ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Infectious Disease

Top Infectious Disease Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DONALD SKILLMAN M.D.

Infectious Disease

7,615

$615K

337
273 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 50%

$81
Average prescription price

Avg: $337

VISHAL SETHI M.D

Infectious Disease

5,278

$2.59M

187
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 50%

$491
Average prescription price

Avg: $337

DIVYA VERMA M.D.

Infectious Disease

4,827

$2.29M

174
45 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 50%

$475
Average prescription price

Avg: $337

SHANTHA MURTHY M.D.

Infectious Disease

4,165

$655K

139
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 50%

$157
Average prescription price

Avg: $337

CHRISTIE BASSETH M.D.

Infectious Disease

4,109

$1.85M

249
30 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 50%

$450
Average prescription price

Avg: $337

LUCIA LOMOTAN M.D.

Infectious Disease

4,071

$1.54M

144
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 50%

$378
Average prescription price

Avg: $337

RICHARD BERG M.D.

Infectious Disease

3,863

$669K

335
282 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 50%

$173
Average prescription price

Avg: $337

DIMITRA MITSANI MD

Infectious Disease

3,539

$234K

117
74 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 50%

$66
Average prescription price

Avg: $337

GREGORY TAYLOR M.D.

Infectious Disease

3,317

$1.73M

232
32 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 50%

$522
Average prescription price

Avg: $337

KJELL WIBERG MD

Infectious Disease

3,205

$1.74M

166
19 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 50%

$544
Average prescription price

Avg: $337

MELCHOR MADARANG MD

Infectious Disease

3,058

$192K

143
71 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 50%

$63
Average prescription price

Avg: $337

LORI FANTRY M.D.

Infectious Disease

2,964

$1.37M

204
23 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 50%

$462
Average prescription price

Avg: $337

MONA GAHUNIA D.O.

Infectious Disease

2,581

$1.37M

170
11 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 50%

$532
Average prescription price

Avg: $337

RAMONA SOBHANI M.D.

Infectious Disease

2,475

$311K

170
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 50%

$126
Average prescription price

Avg: $337

MARIAM KHAMBATY M.D.

Infectious Disease

2,346

$1.3M

114
13 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 50%

$555
Average prescription price

Avg: $337

DALIAH SALAHUDDIN M.D.

Infectious Disease

2,038

$556K

116
71 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 50%

$273
Average prescription price

Avg: $337

SHASTINE ABATE MD

Infectious Disease

1,870

$108K

110
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 50%

$58
Average prescription price

Avg: $337

RAJ CHAWLA MD

Infectious Disease

1,855

$146K

93
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 50%

$79
Average prescription price

Avg: $337

JOHN AUCOTT M.D.

Infectious Disease

1,731

$154K

149
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 50%

$89
Average prescription price

Avg: $337

CHANDRALEKHA BANERJEE MD

Infectious Disease

1,712

$1.02M

79
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 50%

$596
Average prescription price

Avg: $337

ROBIN MC KENZIE M.D.

Infectious Disease

1,676

$730K

178
30 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 50%

$435
Average prescription price

Avg: $337

RAMANI REDDY MD

Infectious Disease

1,673

$367K

219
146 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 50%

$220
Average prescription price

Avg: $337

DEIDRA WOODS MD

Infectious Disease

1,478

$111K

126
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 50%

$75
Average prescription price

Avg: $337

JOHN MCNEIL M.D.

Infectious Disease

1,404

$297K

189
128 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 50%

$212
Average prescription price

Avg: $337

ATIQ RAHMAN M.D.

Infectious Disease

1,391

$106K

90
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 50%

$76
Average prescription price

Avg: $337

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank